本文選題：急性胰腺炎 + 重癥��； 參考：《軍事醫(yī)學》2015年08期

【摘要】：目的檢測急性胰腺炎(acute pancreatitis,AP)患者血漿組織因子途徑抑制劑(tissue factor pathway inhibitor,TFPI)水平,并評價其診斷重癥急性胰腺炎(severe acute pancreatitis,SAP)的臨床價值。方法取68名急性胰腺炎患者,包括SAP患者32例,輕型急性胰腺炎(mild acute pancreatitis,MAP)患者36例;另取同期門診體檢者20例為對照,均入院1 h內抽血樣,收集臨床及實驗室參數(shù),計算APACHEⅡ評分和Ranson評分;采用酶聯(lián)免疫吸附測定(ELISA)方法檢測血漿TFPI水平。結果 MAP組患者血漿TFPI濃度[(3026.81±465.76)pg/ml]較對照組明顯升高[(2468.73±262.39)pg/ml](P0.05),SAP患者血漿TFPI濃度[(4274.25±639.83)pg/ml]較MAP組明顯升高(P0.05)。相關分析顯示,AP患者的血漿TFPI水平與白細胞計數(shù)(WBC)、天冬氨酸轉氨酶(AST)、丙氨酸轉氨酶(ALT)、總膽紅素(TBIL)、肌酐(Cr)、凝血酶原時間(PT)、活化部分凝血活酶時間(APTT)、降鈣素原(PCT)、APACHEⅡ評分和Ranson評分呈顯著正相關(P0.05),與PLT呈顯著負相關(P0.05)。ROC曲線圖分析顯示,血漿TFPI水平診斷SAP發(fā)生的價值AUCSAP=0.902,95%CI=0.845~0.959(P0.05),診斷界值為血漿TFPI濃度4028.83 pg/ml時,敏感度為87%,特異度為78%。結論 SAP患者的血漿TFPI水平可較正常人群和MAP患者顯著升高,并與胰腺炎危重程度顯著相關,可用于診斷SAP。
[Abstract]:Objective to detect the level of plasma tissue factor pathway inhibitor (tissue factor pathway inhibitor TFPI in patients with acute pancreatitis (AP) and to evaluate its clinical value in the diagnosis of severe acute pancreatitis (SAP). Methods Sixty-eight patients with acute pancreatitis, including 32 patients with acute pancreatitis and 36 patients with mild acute pancreatitis (map), and 20 patients with physical examination in the same period were taken as control. Blood samples were taken from all patients within 1 hour after admission, and the clinical and laboratory parameters were collected. Apache 鈪，

本文編號：2089202